Hetero announces the approval and launch of first generic COVIFOR in India for the treatment of Covid-19

Hetero announced that it has received the manufacturing and marketing approval for the investigational antiviral medicine Remdesivir from the DCGI for the treatment of Covid-19. .

Glenmark becomes the first pharma co. in India to receive regulatory approval for oral antiviral Favipiravir, for the treatment of mild to moderate COVID-19

Glenmark Pharmaceuticals announced the launch of antiviral drug Favipiravir for the treatment of mild to moderate COVID-19 patients.

Symbiosis and AstraZeneca Sign Supply Agreement for Sterile Manufacture of COVID-19 Vaccine for Clinical Trials

Symbiosis Pharmaceutical has announced it has signed a supply agreement with AstraZeneca for sterile manufacture of the COVID-19 recombinant...

Catalent Partners with ViralClear Pharmaceuticals on Potential Treatment for COVID-19

Catalent, the leading global provider of advanced delivery technologies, development and consumer health products, announced that it has signed an agreement with ViralClear Pharmaceuticals, Inc. ...

PTC Announces the Initiation of a Phase 2/3 Clinical Trial to Evaluate PTC299 for the Treatment of COVID-19

PTC Therapeutics, Inc. announced that the U.S. FDA has authorized the initiation of a Phase 2/3 trial to investigate PTC299, a dihydroorotate dehydrogenase (DHODH) inhibitor, as a potential treatment...

Saiba AG Selects AGC Biologics to Develop and Produce COVID-19 Vaccine

AGC Biologics, a global biopharmaceutical CDMO has announced it will be partnering with Saiba AG to manufacture a SARS-CoV-2 vaccine to protect against COVID-19.

iNova Pharmaceuticals announces the launch of iPitch 2020

iNova Pharmaceuticals is delighted to announce the launch of a new round of iPitch challenges for 2020. iPitch is a collaborative crowdsourcing program that allows product and packaging developers, innovators....

Neurocrine and Takeda Ink $2 Billion-Plus Neuroscience Development Deal

Neurocrine Biosciences is partnering with Japan’s Takeda Pharmaceutical to develop and commercialize molecules in Takeda's early-to-mid-stage psychiatry pipeline. Takeda granted an exclusive license...

Thermo Fisher Scientific to host Virtual LCMS Conference introducing Orbitrap technology for Asia Pacific region

Thermo Fisher Scientific, the world leader in serving science, announced its upcoming virtual Conference- An exclusive event focused on state of the-art mass spectrometry with a focus to introduce Orbitrap...